Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors

Methods Enzymol. 1995;252:132-46. doi: 10.1016/0076-6879(95)52016-3.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkaloids / pharmacology
  • Alkylating Agents
  • Benzophenanthridines
  • Binding Sites / drug effects
  • Carcinogens / pharmacology*
  • Cysteine / drug effects
  • Enzyme Inhibitors / pharmacology*
  • Hydrogen Peroxide / pharmacology
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / drug effects*
  • Isoquinolines
  • Naphthalenes / pharmacology
  • Nitric Oxide / pharmacology
  • Oxidants / pharmacology*
  • Periodic Acid
  • Perylene / analogs & derivatives
  • Perylene / pharmacology
  • Phenanthridines / pharmacology
  • Phorbol Esters / metabolism
  • Phosphotransferases
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / drug effects*

Substances

  • Alkaloids
  • Alkylating Agents
  • Benzophenanthridines
  • Carcinogens
  • Enzyme Inhibitors
  • Isoenzymes
  • Isoquinolines
  • Naphthalenes
  • Oxidants
  • Phenanthridines
  • Phorbol Esters
  • Periodic Acid
  • Nitric Oxide
  • Perylene
  • hypericin
  • sanguinarine
  • metaperiodate
  • Hydrogen Peroxide
  • chelerythrine
  • Phosphotransferases
  • Protein Kinase C
  • calphostin C
  • Cysteine